A detailed history of Xtx Topco LTD transactions in Immunic, Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 62,145 shares of IMUX stock, worth $73,331. This represents 0.01% of its overall portfolio holdings.

Number of Shares
62,145
Previous 61,695 0.73%
Holding current value
$73,331
Previous $81,000 16.05%
% of portfolio
0.01%
Previous 0.01%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$0.98 - $1.44 $441 - $648
450 Added 0.73%
62,145 $68,000
Q1 2024

May 13, 2024

BUY
$1.14 - $1.53 $22,131 - $29,703
19,414 Added 45.92%
61,695 $81,000
Q4 2023

Feb 13, 2024

BUY
$0.97 - $1.6 $16,630 - $27,432
17,145 Added 68.21%
42,281 $63,000
Q3 2023

Nov 13, 2023

SELL
$1.35 - $2.87 $262,325 - $557,684
-194,315 Reduced 88.55%
25,136 $36,000
Q2 2023

Aug 14, 2023

BUY
$1.33 - $2.51 $197,749 - $373,196
148,684 Added 210.1%
219,451 $550,000
Q1 2023

May 12, 2023

BUY
$1.35 - $2.87 $95,535 - $203,101
70,767 New
70,767 $105,000
Q2 2022

Aug 15, 2022

BUY
$3.13 - $12.25 $62,512 - $244,657
19,972 New
19,972 $69,000

Others Institutions Holding IMUX

About IMMUNIC, INC.


  • Ticker IMUX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,565,000
  • Market Cap $36.1M
  • Description
  • Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...
More about IMUX
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.